leishmania complex vectorborn disease caps protozoan parasite genus leishmania leishdnavax multiantigen cell epitopeenrich dna vaccine candid human leishmaniasi proven immunogen show prophylact efficacy prelim studi describe safety test nav mouse rat complement demons tower leishmaniainfect biodistribut persist examine follow single repeat intruder id administer vector distribute system accueil upon inject although vector clear tissue within day last inject persist skin site drain lymph node value singles repeateddos toxic noninfect reveal concern also well tower taken together result substantial favor profil infect anim thu support init clinic trial prevent therapeutic applied 